MedTrace Logo

Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.

NCT01949077 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-10-30

No results posted yet for this study

Summary

The purpose of the study is to determine differences in levels of serum chemokines from patients undergoing treatment with Boceprevir. The aim is to determine if non-responders have significantly different levels of chemokines than responders.

Conditions

  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Michael W Fried, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01949077 on ClinicalTrials.gov